Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Emory University |
---|---|
Information provided by: | Emory University |
ClinicalTrials.gov Identifier: | NCT00576329 |
To determine whether use of topical 0.4% ketorolac has any effect on pupil size during vitreoretinal surgery.
Condition | Intervention | Phase |
---|---|---|
Surgery |
Drug: Ketorolac |
Phase II Phase III |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double Blind (Subject, Investigator), Placebo Control, Single Group Assignment, Efficacy Study |
Official Title: | Topical 0.4% Ketorolac for the Inhibition of Miosis During Vitreoretinal Surgery: a Randomized, Placebo-Controlled, Double-Masked Study |
Enrollment: | 76 |
Study Start Date: | November 2006 |
Study Completion Date: | October 2007 |
Arms | Assigned Interventions |
---|---|
A: Placebo Comparator |
Drug: Ketorolac
Topical use before surgery
|
B: Experimental |
Drug: Ketorolac
Topical use before surgery
|
Other outcomes will be to assess postoperative pain and inflammation and visual acuity.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Emory University ( Stephen J. Kim ) |
Study ID Numbers: | IRB00000517 |
Study First Received: | December 17, 2007 |
Last Updated: | December 17, 2007 |
ClinicalTrials.gov Identifier: | NCT00576329 |
Health Authority: | United States: Institutional Review Board |
vitreoretinal surgery, ketorolac, Acular, mydriasis |
Miosis Ketorolac Mydriasis Ketorolac Tromethamine |
Anti-Inflammatory Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Cyclooxygenase Inhibitors Enzyme Inhibitors Pharmacologic Actions Analgesics, Non-Narcotic |
Sensory System Agents Therapeutic Uses Anti-Inflammatory Agents, Non-Steroidal Analgesics Peripheral Nervous System Agents Antirheumatic Agents Central Nervous System Agents |